City Center Advisors LLC’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,460
Closed -$209K 182
2026
Q1
$209K Sell
7,460
-5,265
-41% -$140K 0.19% 152
2025
Q4
$317K Buy
+12,725
New +$321K 0.29% 106
2024
Q3
Sell
-8,054
Closed -$224K 192
2024
Q2
$224K Hold
8,054
0.26% 145
2024
Q1
$224K Buy
+8,054
New +$223K 0.26% 145

Other funds holding PFE

City Center Advisors LLC's PFE Position: Q2 2026 in Review

City Center Advisors LLC sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,460 shares — an estimated $209K sold.

City Center Advisors LLC first reported a position in PFE in Q1 2024 and held it in 4 quarters. The position peaked at $317K in Q4 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • City Center Advisors LLC reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • City Center Advisors LLC sold 7,460 Pfizer shares in Q2 2026, an estimated $209K.
  • City Center Advisors LLC first reported a position in Pfizer in Q1 2024 and held it in 4 quarters.
  • City Center Advisors LLC's Pfizer position peaked at $317K in Q4 2025.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on City Center Advisors LLC's 13F filing for Q2 2026, filed 7 Jul 2026.